Skip to main content
editorial
. 2017 Jun 15;11(4):317–370. doi: 10.1007/s12072-017-9799-9

Table 3.

Groups where HCC surveillance is recommended

HCC risk (per year)
Cirrhotic hepatitis patients
 HBV 3–5%
 HCV 2–7%
 NASH 2–4%
 Genetic hemochromatosis Unknown, but probably >1.5%
 Primary biliary cirrhosis 2–3%
 Alpha 1 antitrypsin (A1AT) deficiency Unknown, but probably >1.5%
 Autoimmune hepatitis
 Other etiologies Unknown
Chronic HBV carriers
 Noncirrhotic (HBsAg positive)
  Asian females >50 years 0.3–0.6%
  Asian males >40 years 0.4–0.6%
  Africans aged >20 years NA
  History of HCC in the family NA